Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 10, 2008BloodOpen Access

CD20 up-regulation in pediatric B-cell precursor acute lymphoblastic leukemia during induction treatment: setting the stage for anti-CD20 directed immunotherapy

View Full Paper
Ask AI
Bookmark
Share

Authors

MDMichael DworzakUniversity of ViennaASAngela SchumichSt Anna Children's HospitalDPDieter PrintzSt Anna Children's Hospital

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Dworzak et al. (2008) studied this question.

synapsesocial.com/papers/6a1dcc0d79ea62caf6602167https://doi.org/10.1182/blood-2008-06-164129
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Standardization of flow cytometric minimal residual disease evaluation in acute lymphoblastic leukemia: Multicentric assessment is feasible2008 · 158 citations
  2. 2Comparison of diagnostic and relapse flow cytometry phenotypes in childhood acute lymphoblastic leukemia: Implications for residual disease detection: A report from the children's oncology group2005 · 92 citations
  3. 3Early relapse after rituximab chemoimmunotherapy2007 · 6 citations